SEC Tracker
Get the app

AbbVie ABBV

Guidance Including the Impact of Acquired IPR&D and Milestones Expense

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when AbbVie files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Johnson & Johnson JNJ public float $367.0B, Jun 29, 2025
  2. Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
  3. Merck MRK public float $198.1B, Jun 30, 2025
  4. Amgen AMGN public float $150.1B, Jun 30, 2025
  5. Pfizer PFE public float $138.0B, Jun 29, 2025